Dr. Amrita Y. Krishnan

Claim this profile

City of Hope Comprehensive Cancer Center

Studies Plasma Cell Neoplasm
Studies Multiple Myeloma
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
City Of Hope Comprehensive Cancer Center
Image of trial facility.
City Of Hope Medical Center

Clinical Trials Amrita Y. Krishnan is currently running

Image of trial facility.

Lenalidomide +/- Daratumumab

for Multiple Myeloma

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria

More about Amrita Y. Krishnan

Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Amrita Y. Krishnan has experience with
  • Daratumumab/rHuPH20
  • Lenalidomide
  • Daratumumab
Breakdown of trials Amrita Y. Krishnan has run
Plasma Cell Neoplasm
Multiple Myeloma
Primary Cutaneous Amyloidosis
Amyloidosis

Other Doctors you might be interested in

Sumanta K. PalCity of Hope Medical Center
Anna Pawlowska, MDCity of Hope Comprehensive Cancer Center
Sasan Fazeli, MDCity of Hope Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amrita Y. Krishnan specialize in?
Amrita Y. Krishnan focuses on Plasma Cell Neoplasm and Multiple Myeloma. In particular, much of their work with Plasma Cell Neoplasm has involved treating patients, or patients who are undergoing treatment.
Is Amrita Y. Krishnan currently recruiting for clinical trials?
Yes, Amrita Y. Krishnan is currently recruiting for 1 clinical trial in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Amrita Y. Krishnan has studied deeply?
Yes, Amrita Y. Krishnan has studied treatments such as Daratumumab/rHuPH20, Lenalidomide, Daratumumab.
What is the best way to schedule an appointment with Amrita Y. Krishnan?
Apply for one of the trials that Amrita Y. Krishnan is conducting.
What is the office address of Amrita Y. Krishnan?
The office of Amrita Y. Krishnan is located at: City of Hope Comprehensive Cancer Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top